EXI3:XETRA:XETRA-iShares Dow Jones Industrial Average UCITS ETF (DE) (EUR)

ETF | Others |

Last Closing

USD 413.8

Change

-1.15 (-0.28)%

Market Cap

USD 0.30B

Volume

679.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-14 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.13 (+0.25%)

USD 426.26B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.05 (+0.28%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.01 (-0.04%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.04 (+0.12%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.01 (+0.04%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

-0.13 (-0.29%)

USD 104.42B
8R80:XETRA Amundi Index Solutions - Amund..

+0.30 (+0.21%)

USD 104.42B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.14 (+0.27%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

-0.10 (-0.10%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-1.58 (-0.26%)

USD 80.38B

ETFs Containing EXI3:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 21.90% 79% B- 78% C+
Dividend Return 0.68% 9% A- 8% B-
Total Return 22.58% 80% B- 79% B-
Trailing 12 Months  
Capital Gain 29.43% 78% C+ 78% C+
Dividend Return 0.96% 9% A- 11% F
Total Return 30.40% 79% B- 78% C+
Trailing 5 Years  
Capital Gain 64.24% 80% B- 80% B-
Dividend Return 5.46% 27% F 22% F
Total Return 69.70% 81% B- 79% B-
Average Annual (5 Year Horizon)  
Capital Gain 11.69% 74% C 72% C
Dividend Return 12.05% 75% C 72% C
Total Return 0.36% 30% F 19% F
Risk Return Profile  
Volatility (Standard Deviation) 11.39% 55% F 64% D
Risk Adjusted Return 105.73% 96% N/A 96% N/A
Market Capitalization 0.30B 53% F 47% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.